P I | IT) Y ‘ (MMMA/INW M 05 3550/3 'HIr/I‘
‘ . I \ I I N

5;). CW... em. I ﬁnd/my (:50. 4
The patient isa. year-old female. Dale of last menstruaIperiod: Not given. ‘ W M” -

P | NOSIS:C left breast. ' llyi‘ wk ; {II-‘3 UUID:2616F7OD-3E15-455A-8907-65694595F726
ESEPOPDDAIEGNOSISEame. (,thF 'W c TCGA-BH-AlSU-DlA-PR Rﬁldlﬁliﬂted

. “PRWEDURE: s°"“”e' ”we ”bps” ”‘3‘ mas"‘°‘°my- lllllllllll |||H||||lllllIlllIllIlllllllIllllllllllll
I . |||||||||Illlllllllllllllllll|||l|l||||||l||lllllllllllll
IIIIIIIIII lllllllllllll III III III III! I IIIIIIIIIIIIII Ill

 

III
III
III

ADDENDA:

Addendum
ESTROGEN/PROGESTERONE AND HER-ZINEU REPORT

Using appropriate positive and negative controls, the test for the presence of mess hormone receptor proteins ls
performed by the immunoperoxidase method, and reported according to the NIH consensus statement on adjuvant

. therapy for breast cancer, at A positive ER or PR tumor shows any nuclear immunostaining, and is
semiquantltated as indicated below.

Resuit Semiquantitative Statement
ER positive Percent cells staining as: (0 20%: 1+ 30%, 2+ 30%. 3+ 20%)
PR positive Percent cells staining as: (0 70%) 1+ 10%, 2+ 10%, 3+ 10%)

HER-ZINEU DAKO HERCEPTEST: A STRONG COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE THAN 10% OF
THE TUMOR CELLS. HER-ZINEU IS INTERPRETED AS STRONGLY POSITIVE (SCORE 3+).

FINAL DIAGNOSIS:

PART 1: LEFT BREAST, TOTAL MASTECTOMY —

A. INFILTRATING DUCEQARCINOMAJWO LESIONS. 3&5 1.7 x 1.5 CM IN THE LOWER OUTER OUADRANT I
, fANQ§Q§3§ x 2.5 CM IN TTIE UPPER OUTER OUADRAN‘D NOTTINGHAM SCORE S'OUT OF‘s (TUBULES 3,
NUCLEI 3. Mlﬁﬁis 3T.
LYMPHOVASCULAR INVASION IDENTIFIED.
DUCTAL CARCINOMA lN-SITU, SOLID TYPE, NUCLEAR GRADE 3 WITH COMEDO-TYPE NECROSIS,
COMPRISING LESS THAN 5% OF TUMOR.
SURGICAL MARGINS NEGATIVE FOR INFILTRATING DUCT CARCINOMA AND DUCTAL CARCINOMA IN-
SITU.
INFILTRATING DUCT CARCINOMA FOCALLY APPROACHES VERY CLOSELY MARGIN OF EXCISION IN
THE LOWER OUTER QUADRANT (WITHIN 0.2 CM). .
NIPPLE NEGATIVE FOR TUMOR.
CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITE.
TWO LYMPH NODEs. POSITIVE FOR METASTATIC CARCINOMA (2 OUT OF 2).

;pr m P on

PART 2: LEFT BREAST, NEW ANTERIOR-INFERIOR MARGIN, EXCISION —
SKIN AND SUBCUTANEOUS TISSUE, NEGATIVE FOR TUMOR.

PART 3: LEFT SENTINEL LYMPH NODE #1, BIOPSY -
ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1 OUT OF 1).

PART 4: LEFT SENTINEL LYMPH NODE #2, BIOPSY -
ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0 OUT OF 1).

PART 5: LEFT SENTINEL LYMPH NODE #3, BIOPSY —
ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1 OUT OF 1).

PART 6: LEFT AXILLARY CONTENTS, EXCISION —

FIVE OF ELEVEN LYMPH NODES fOS‘ITIVE'FOR METASTATIC CARCINOMA, THREE WITH EXTRACAPSULAR
EXTENSION. ' T "

PART 7: RIGHT BREAST TISSUE. EXCISION (396 GRAMS‘) -
A. FOCAL ATYPICAL DUCTAL HYPERPLASIA ASSOCIATED WITH MICROCALCIFICATIONS.

 
 
 
 
  
 

  
   

 

    

e. CALCIFlED FIBROADENOMA.

c. FIBROCYSTIC CHANGES WITH MICROCALCIFICATIONS.

D. SCLEROSING ADENOSIS. 33;;ka

E. SCLEROSING INTRADUCTAL PAPILLOMA. Mi

F. UNREMARKAaLE SKIN. S‘Jiﬁ‘iiiiiimm
W ::;1:I:;:;::°“‘W.ﬁ

COMMENT:
Estrogen receptor, progesterone receptor and HER-Zineu immunostains will be ordered and subsequently reported in an
addendum. lmmunostaining for e-cadherin and myosin heavy chain conﬁrm the interpretation of changes in the right
breast tissue.

SYNOPTIC -
A. Laterality; g

1. Right
B. Procedure: 2
- 1. Segmentectomy
2. Simple mastectomy
C. Location: g,_2
1. Central subareolar
2. U00
3. UIQ
D. Size of tumor (maximum dimension invasive com
E. Type (invasive component): 1

2. Left

PRIMARY INVASIVE CARCINOM OF BREAST

3. Modiﬁed radical mastectomy
4. Re—excision

4. L00
5. HQ
6. Not speciﬁed
ponenl by gross or microscopic exam): 2 and . cm

1. Ductal, NOS 5. Cribriform 9. Metaplastic
2. Tubular 6. Papillary 10. Other
3. Muclnous 7. Lobular »
4. Medullary 8. Carcinoid like
F. lf lobular carcinoma, specify type: M
1: Classical 4. Signet ring‘ 7. Pleomorphic
2. Solid 5. Trabecular
3. Alveolar 6. Tubulobular
G. Nottingham Score:
G1. Nuclear grade: g
62. Tubule formation: a
G3. Mitotic activity score: g
G4. Total Nottingham score: 3
Gs. Nottingham grade (1, 2, 3): g
H. Angiolymphalic invasion: 2
1. No 2. Yes
I. Dermal lymphatic invasion: g
1. Yes 2. No 3. Not applicable
J. Calciﬁcation: _1_
1. No 2. Yes - benign zones 3. Yes — malignant zones
K. Type of in situ component: ;
1. Cribriform 4. Micropaplllary ' 7. Lobular
2. Solid 5. Apocrine
3. Papillary 6. Comedo
L. Percentage of tumor occupied by in situ component: <_5%
M. Surgical margins involved by invasive component: _1_ '
1. No 2. Yes — focal 3. Yes ~— diﬁ‘use
N. Surgical margins involved by in situ component: _1_
1. No 2. Yes - focal 3. Yes - diffuse
O. Pagel’s disease of nipple: 2
1. Yes 2. No
P. Number of positive lymph nodes: g
Q. Total number of lymph nodes examined: E
R. Sentinel node metastasis: 1
1. Yes 2. No
8. Only micrometastases to lymph nodes (none larger than 0.2 cm): _2_
1. Yes 2. No
T. Metastasis/es to a lymph node 2 cm. or more in greatest dimension: _1_
1. Yes 2. No
U. Lymph node metastasis/es with extracapsular extension: 1
1. Yes 2. No
V. Metastases to ipsilateral internal mammary lymph node (if applicable): M.
1. Yes 2. No
W. Skin involved (ulceration): g
1. Yes 2. No
X. Non-neoplastic breast tissue: § / g I g / g .
1. ADH 4. Fibroadenoma 7. LClS
2. ALH 5. Papilloma 8. Other
3. Radical scar 6. FCD
Y. Multicentricity/multifocality of invasive foci: 1
1. Yes 2. No

Z. TNM stage: T3 15 N ZaﬁM xg

